Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter W Kallemeijn

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Plos Pathogens|October 10, 2022
Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entryLalita Priyamvada, Wouter W Kallemeijn, Monica Faronato, et al.
Chemical Communications (Cambridge, England)|August 31, 2012
Tuning the leaving group in 2-deoxy-2-fluoroglucoside results in improved activity-based retaining β-glucosidase probesMarthe T C Walvoort, Wouter W Kallemeijn, Lianne I Willems, et al.
Journal of Lipid Research|November 12, 2013
Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysisPaulo Gaspar, Wouter W Kallemeijn, Anneke Strijland, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 16, 2015
Comparing Cyclophellitol N-Alkyl and N-Acyl Cyclophellitol Aziridines as Activity-Based Glycosidase ProbesJianbing Jiang, Thomas J M Beenakker, Wouter W Kallemeijn, et al.
Blood|April 12, 2012
Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysisSarah M Lo, Murim Choi, Jun Liu, et al.
Blood|September 28, 2011
CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101Margot Jak, Gregor G W van Bochove, Eric A Reits, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2014
LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearanceMichelle Rothaug, Friederike Zunke, Joseph R Mazzulli, et al.
Plos One|February 17, 2017
Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probesWouter W Kallemeijn, Saskia Scheij, Sascha Hoogendoorn, et al.
The FEBS Journal|January 3, 2019
In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profilingChi-Lin Kuo, Wouter W Kallemeijn, Lindsey T Lelieveld, et al.
Journal of Lipid Research|October 14, 2017
In situ visualization of glucocerebrosidase in human skin tissue: zymography versus activity-based probe labelingJeroen van Smeden, Irini M Dijkhoff, Richard W J Helder, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Plos Pathogens|October 10, 2022
Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entryLalita Priyamvada, Wouter W Kallemeijn, Monica Faronato, et al.
Chemical Communications (Cambridge, England)|August 31, 2012
Tuning the leaving group in 2-deoxy-2-fluoroglucoside results in improved activity-based retaining β-glucosidase probesMarthe T C Walvoort, Wouter W Kallemeijn, Lianne I Willems, et al.
Journal of Lipid Research|November 12, 2013
Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysisPaulo Gaspar, Wouter W Kallemeijn, Anneke Strijland, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 16, 2015
Comparing Cyclophellitol N-Alkyl and N-Acyl Cyclophellitol Aziridines as Activity-Based Glycosidase ProbesJianbing Jiang, Thomas J M Beenakker, Wouter W Kallemeijn, et al.
Blood|April 12, 2012
Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysisSarah M Lo, Murim Choi, Jun Liu, et al.
Blood|September 28, 2011
CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101Margot Jak, Gregor G W van Bochove, Eric A Reits, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2014
LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearanceMichelle Rothaug, Friederike Zunke, Joseph R Mazzulli, et al.
Plos One|February 17, 2017
Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probesWouter W Kallemeijn, Saskia Scheij, Sascha Hoogendoorn, et al.
The FEBS Journal|January 3, 2019
In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profilingChi-Lin Kuo, Wouter W Kallemeijn, Lindsey T Lelieveld, et al.
Journal of Lipid Research|October 14, 2017
In situ visualization of glucocerebrosidase in human skin tissue: zymography versus activity-based probe labelingJeroen van Smeden, Irini M Dijkhoff, Richard W J Helder, et al.
Pageof 5